Axitan
London
About Axitan
Axitan develops a microalgae-production platform for the development of novel and safe products. Axitan is an algal biotechnology that facilitates a cost effective transition away from conventional antibiotics within the animal agriculture industry. Axitan aims to tackle some of the industries main challenges by applying algal biotechnology to deliver innovative products that support production, focusing on improving yield, quality and profitability, and being sustainable and resource efficient.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: axitan.com
- Phone: [email protected]
Industries & Categories
Agriculture, Biotechnology, Sustainability
Canonical: https://fsome.com/organization/axitan-17568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.